Total Payments
$4,067
2023 Payments
$308.93
Companies
27
Transactions
259
Medicare Patients
2,979
Medicare Billing
$326,047
Payment Breakdown by Category
Food & Beverage$4,067 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,067 | 259 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $1,405 | 94 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $464.69 | 29 | $0 (2023) |
| PFIZER INC. | $376.43 | 24 | $0 (2023) |
| Valeant Pharmaceuticals North America LLC | $266.54 | 13 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $239.77 | 14 | $0 (2023) |
| Merck Sharp & Dohme LLC | $225.62 | 18 | $0 (2022) |
| Celgene Corporation | $142.29 | 6 | $0 (2023) |
| Gilead Sciences, Inc. | $128.75 | 9 | $0 (2023) |
| Allergan Inc. | $107.66 | 8 | $0 (2018) |
| Ferring Pharmaceuticals Inc. | $105.68 | 6 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $308.93 | 16 | AbbVie Inc. ($86.82) |
| 2022 | $792.53 | 46 | ABBVIE INC. ($278.80) |
| 2021 | $396.58 | 24 | AbbVie Inc. ($220.18) |
| 2020 | $313.92 | 21 | AbbVie Inc. ($157.70) |
| 2019 | $437.94 | 29 | AbbVie, Inc. ($192.50) |
| 2018 | $1,007 | 71 | AbbVie, Inc. ($268.36) |
| 2017 | $810.40 | 52 | Valeant Pharmaceuticals North America LLC ($266.54) |
All Payment Transactions
259 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/15/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $28.33 | General |
| Category: Neuroscience | ||||||
| 05/03/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Gastroenterology | ||||||
| 04/18/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Gastroenterology | ||||||
| 03/23/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: IMMUNOLOGY | ||||||
| 03/21/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Immunology | ||||||
| 03/15/2023 | AbbVie Inc. | RINVOQ (Biological), HUMIRA | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: IMMUNOLOGY | ||||||
| 03/09/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/06/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Gastroenterology | ||||||
| 02/28/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: IMMUNOLOGY | ||||||
| 02/27/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $32.25 | General |
| Category: Neuroscience | ||||||
| 02/16/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 02/09/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.98 | General |
| 01/31/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $25.31 | General |
| Category: Neuroscience | ||||||
| 01/30/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: IMMUNOLOGY | ||||||
| 01/12/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: IMMUNOLOGY | ||||||
| 01/05/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/22/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/29/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/01/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: IMMUNOLOGY | ||||||
| 10/27/2022 | ABBVIE INC. | RINVOQ (Biological), HUMIRA | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: VIROLOGY | ||||||
| 10/20/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Gastroenterology | ||||||
| 10/14/2022 | PFIZER INC. | XELJANZ (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/12/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Gastroenterology | ||||||
| 10/12/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 707 | 740 | $238,339 | $76,315 |
| 2022 | 11 | 809 | 877 | $292,082 | $88,961 |
| 2021 | 11 | 763 | 828 | $269,459 | $85,849 |
| 2020 | 11 | 700 | 774 | $237,540 | $74,922 |
Total Patients
2,979
Total Services
3,219
Medicare Billing
$326,047
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 184 | 184 | $77,464 | $22,278 | 28.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 78 | 78 | $40,618 | $16,413 | 40.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 127 | 154 | $39,314 | $13,637 | 34.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 128 | 129 | $36,176 | $7,398 | 20.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 57 | 57 | $19,094 | $6,745 | 35.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 28 | 28 | $10,465 | $5,122 | 48.9% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 31 | 34 | $10,580 | $3,106 | 29.4% |
| 91200 | Measurement of liver stiffness | Office | 2023 | 74 | 76 | $4,628 | $1,616 | 34.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 108 | 108 | $56,473 | $21,231 | 37.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 159 | 219 | $56,164 | $20,126 | 35.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 163 | 163 | $71,206 | $15,550 | 21.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 162 | 164 | $46,264 | $8,647 | 18.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 65 | 65 | $21,976 | $8,082 | 36.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 33 | 33 | $12,510 | $6,175 | 49.4% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 38 | 41 | $12,920 | $3,567 | 27.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 11 | 11 | $4,180 | $2,066 | 49.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 12 | $4,356 | $1,575 | 36.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 18 | $3,281 | $1,096 | 33.4% |
| 91200 | Measurement of liver stiffness | Office | 2022 | 42 | 43 | $2,752 | $846.28 | 30.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 158 | 219 | $56,252 | $20,839 | 37.0% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 80 | 80 | $41,830 | $16,550 | 39.6% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 140 | 140 | $58,455 | $12,972 | 22.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 91 | 91 | $30,809 | $11,146 | 36.2% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 147 | 150 | $42,498 | $8,634 | 20.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 24 | 24 | $9,168 | $4,639 | 50.6% |
About Ian Steele
Ian Steele is a Gastroenterology healthcare provider based in Melbourne, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962584664.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ian Steele has received a total of $4,067 in payments from pharmaceutical and medical device companies, with $308.93 received in 2023. These payments were reported across 259 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($4,067).
As a Medicare-enrolled provider, Steele has provided services to 2,979 Medicare beneficiaries, totaling 3,219 services with total Medicare billing of $326,047. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Melbourne, FL
- Active Since 10/20/2006
- Last Updated 03/10/2020
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1962584664
Products in Payments
- XIFAXAN (Drug) $495.96
- XELJANZ (Drug) $297.70
- HUMIRA (Biological) $267.23
- Mavyret (Drug) $255.80
- Humira (Biological) $255.45
- ENTYVIO (Biological) $174.67
- SKYRIZI (Biological) $165.01
- MAVYRET (Drug) $142.94
- ZEPOSIA (Drug) $142.29
- XIFAXANIBSD (Drug) $116.39
- LINZESS (Drug) $107.63
- CLENPIQ (Drug) $105.68
- DIFICID (Drug) $101.97
- VIBERZI (Drug) $96.27
- GATTEX (Drug) $89.71
- RINVOQ (Biological) $89.00
- RENFLEXIS (Biological) $78.90
- INFLECTRA (Biological) $78.73
- Entyvio (Biological) $75.84
- Viekira (Drug) $61.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Melbourne
Andrew Schmidt, Md, MD
Gastroenterology — Payments: $9,361
Gastroenterology $9,361
Shireen Gadallah, M.d, M.D
Gastroenterology — Payments: $6,843
Gastroenterology $6,843
Charles Farrington, Md, MD
Gastroenterology — Payments: $6,331
Gastroenterology $6,331
Dr. John Turse, Md, MD
Gastroenterology — Payments: $4,870
Gastroenterology $4,870
Dr. Peter Koretsky, Md, MD
Gastroenterology — Payments: $4,838
Gastroenterology $4,838
Dr. Gita Koshy, M.d, M.D
Gastroenterology — Payments: $4,501
Gastroenterology $4,501